Paid Clinical Trials El Paso

Discover 1,027 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,027

Observational StudyRegistry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction

Recruiting

Sponsor:

Axogen Corporation

Location:

Aurora CO, Lubbock TX, Omaha NE, Kansas City KSshow 33 more

Code:

NCT01526681

Conditions

Peripheral Nerve Injuries

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Processed Human Nerve Graft

Standard Treatment, Autogenous Nerve Graft, Direct Suture, etc.

Autogenous Nerve Graft

Nerve Tube Conduit

Autologous Breast Reconstruction with Neurotization

Remibrutinib vs. TeriflunomideEfficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Denver CO, Aurora CO, Colorado Springs CO, Kansas City KSshow 59 more

Code:

NCT05156281

Conditions

Relapsing Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Remibrutinib

Teriflunomide

IptacopanA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Aurora CO, Chubbuck ID, Kansas City MO, Glendale AZshow 10 more

Code:

NCT04557462

Conditions

Primary IgA Nephropathy

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

LNP023

BT8009Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Recruiting

PHASE1

PHASE2

Sponsor:

BicycleTx Limited

Location:

Denver CO, Las Vegas NV, Dallas TX, Houston TXshow 10 more

Code:

NCT04561362

Conditions

Urinary Bladder Neoplasm

Triple Negative Breast Neoplasms

Hormone Receptor Positive, HER2-negative Neoplasms

Hormone Receptor Positive, HER2-low Neoplasms

Breast Neoplasms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BT8009

Pembrolizumab

CX-4945Dose-escalation Study of Oral CX-4945

Recruiting

PHASE1

Sponsor:

Cylene Pharmaceuticals

Location:

Loveland CO, Fort Collins CO, Scottsdale AZ, Houston TX

Code:

NCT00891280

Conditions

Advanced Solid Tumors

Breast Cancer

Inflammatory Breast Cancer

Castleman's Disease

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CX-4945 oral formulation

BIIB091 & DRFA Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)

Recruiting

PHASE2

Sponsor:

Biogen

Location:

Aurora CO, Albuquerque NM, Kansas City KS, Scottsdale AZshow 19 more

Code:

NCT05798520

Conditions

Relapsing Forms of Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

BIIB091

DRF

Placebo

NTLA-2002HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

Recruiting

PHASE3

Sponsor:

Intellia Therapeutics

Location:

Centennial CO, Colorado Springs CO, Scottsdale AZ, Dallas TXshow 13 more

Code:

NCT06634420

Conditions

Hereditary Angioedema

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

NTLA-2002

Normal Saline IV Administration

NX-1607A Study of NX-1607 in Adults With Advanced Malignancies

Recruiting

PHASE1

Sponsor:

Nurix Therapeutics, Inc.

Location:

Aurora CO, Oklahoma City OK, Los Angeles CA, Houston TXshow 5 more

Code:

NCT05107674

Conditions

Ovarian Cancer, Epithelial

Gastric Cancer

GastroEsophageal Junction (GEJ) Cancer

Head and Neck Squamous Cell Carcinoma

Metastatic or Unresectable Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

NX-1607

Paclitaxel

Single vs. MultipleComparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

Recruiting

Sponsor:

Weill Medical College of Cornell University

Location:

Aurora CO, Salt Lake City UT, Lincoln NE, Omaha NEshow 45 more

Code:

NCT04124120

Conditions

Heart Diseases

Coronary Artery Disease

Coronary Artery Bypass Grafting

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Single arterial graft

Multiple arterial grafting

IMM-1-104A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

Recruiting

PHASE1

PHASE2

Sponsor:

Immuneering Corporation

Location:

Denver CO, Scottsdale AZ, Rochester MN, San Antonio TXshow 15 more

Code:

NCT05585320

Conditions

Advanced Solid Tumor

Pancreatic Adenocarcinoma

Malignant Melanoma (Cutaneous)

Non-small Cell Lung Cancer (NSCLC)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

IMM-1-104 Monotherapy (Treatment Group A)

IMM-1-104 + modified Gemcitabine/nab-Paclitaxel (Treatment Group B)

IMM-1-104 + modified FOLFIRINOX (Treatment Group C)

IMM-1-104 + dabrafenib (Treatment Group D)

IMM-1-104 + pembrolizumab (Treatment Group E)